Severe asthma can be difficult to manage when regular inhaled medicines do not provide adequate symptom control. Biologic therapies are specialized medicines designed to target certain immune system pathways involved in specific types of asthma. They may help reduce asthma attacks, improve symptom control, and decrease the need for oral corticosteroids in eligible patients. Understanding how biologics work, who may benefit from them, and how treatment is monitored can help patients have informed discussions with healthcare professionals. Treatment decisions depend on asthma type, symptoms, medical history, test results, and individual response to therapy over time.
Severe asthma is a complex condition that may continue to cause coughing, wheezing, chest tightness, and shortness of breath despite the use of standard treatments. For some people, healthcare professionals may consider biologic therapy when asthma remains poorly controlled. These medicines are different from traditional asthma treatments because they target specific cells or proteins involved in inflammation.
Biologics are usually designed for people with certain forms of severe asthma, particularly when inflammation plays an important role in their symptoms. Different biologic medicines target different pathways within the immune system. For example, some may affect immunoglobulin E, while others target interleukins or other inflammatory signals associated with particular asthma patterns.
Before considering a biologic, a healthcare professional may evaluate the person's asthma symptoms, history of asthma attacks, current medications, blood test results, allergy information, and other health factors. This assessment can help identify whether a particular type of biologic may be appropriate.
Key points about how biologics may work include:
Biologic therapy does not replace the need for an individualized asthma management plan. People receiving these treatments may still need other prescribed medicines and should continue following guidance from their healthcare professional.
For eligible individuals, biologic treatment may help reduce the frequency of severe asthma exacerbations. Some people may experience improved symptom control and may require fewer courses of oral corticosteroids. However, results can vary because severe asthma can have different causes and inflammatory patterns.
Healthcare professionals generally monitor treatment over time to assess changes in symptoms, asthma attacks, lung function, and medication requirements. The method and frequency of administration can also vary depending on the specific biologic prescribed.
Important considerations include:
Understanding severe asthma and its underlying inflammatory patterns can help explain why treatment approaches differ between individuals. Biologic therapies represent one option that may be considered for eligible patients whose asthma remains difficult to control. A healthcare professional can provide guidance based on individual symptoms, medical history, testing, and response to treatment. This information is provided for educational purposes only and is not intended as medical advice, diagnosis, treatment, or sales and service information.